Formoterol Thrice Weekly Does Not Result in the Development of Tolerance to Bronchoprotection

Formoterol Thrice Weekly Does Not Result in the Development of Tolerance to Bronchoprotection

BACKGROUND: Loss of bronchoprotection routinely follows regular treatment with beta2-agonists. There are no data on the effects on bronchoprotection for thrice weekly use of a beta2-agonist.

Bibliographic Details
Main Authors: Beth E Davis, John K Reid, Donald W Cockcroft
Format: Article
Language:English
Published: Hindawi Limited 2003-01-01
Series:Canadian Respiratory Journal
Online Access:http://dx.doi.org/10.1155/2003/148740
id doaj-c57b2cda96e64c0a819f984a9d9e126e
record_format Article
spelling doaj-c57b2cda96e64c0a819f984a9d9e126e2021-07-02T02:14:57ZengHindawi LimitedCanadian Respiratory Journal1198-22412003-01-01101232610.1155/2003/148740Formoterol Thrice Weekly Does Not Result in the Development of Tolerance to BronchoprotectionBeth E Davis0John K Reid1Donald W Cockcroft2Division of Respiratory Medicine, Department of Medicine, Royal University Hospital, Saskatoon, Saskatchewan, CanadaDivision of Respiratory Medicine, Department of Medicine, Royal University Hospital, Saskatoon, Saskatchewan, CanadaDivision of Respiratory Medicine, Department of Medicine, Royal University Hospital, Saskatoon, Saskatchewan, CanadaBACKGROUND: Loss of bronchoprotection routinely follows regular treatment with beta2-agonists. There are no data on the effects on bronchoprotection for thrice weekly use of a beta2-agonist.http://dx.doi.org/10.1155/2003/148740
collection DOAJ
language English
format Article
sources DOAJ
author Beth E Davis
John K Reid
Donald W Cockcroft
spellingShingle Beth E Davis
John K Reid
Donald W Cockcroft
Formoterol Thrice Weekly Does Not Result in the Development of Tolerance to Bronchoprotection
Canadian Respiratory Journal
author_facet Beth E Davis
John K Reid
Donald W Cockcroft
author_sort Beth E Davis
title Formoterol Thrice Weekly Does Not Result in the Development of Tolerance to Bronchoprotection
title_short Formoterol Thrice Weekly Does Not Result in the Development of Tolerance to Bronchoprotection
title_full Formoterol Thrice Weekly Does Not Result in the Development of Tolerance to Bronchoprotection
title_fullStr Formoterol Thrice Weekly Does Not Result in the Development of Tolerance to Bronchoprotection
title_full_unstemmed Formoterol Thrice Weekly Does Not Result in the Development of Tolerance to Bronchoprotection
title_sort formoterol thrice weekly does not result in the development of tolerance to bronchoprotection
publisher Hindawi Limited
series Canadian Respiratory Journal
issn 1198-2241
publishDate 2003-01-01
description BACKGROUND: Loss of bronchoprotection routinely follows regular treatment with beta2-agonists. There are no data on the effects on bronchoprotection for thrice weekly use of a beta2-agonist.
url http://dx.doi.org/10.1155/2003/148740
work_keys_str_mv AT bethedavis formoterolthriceweeklydoesnotresultinthedevelopmentoftolerancetobronchoprotection
AT johnkreid formoterolthriceweeklydoesnotresultinthedevelopmentoftolerancetobronchoprotection
AT donaldwcockcroft formoterolthriceweeklydoesnotresultinthedevelopmentoftolerancetobronchoprotection
_version_ 1721343637240938496

Similar Items